Stem Cell Culture Medium for Uniform TLR-Induced Polarization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for inducing multipotent stem cells into specific inflammatory or anti-inflammatory phenotypes are inefficient and lack uniformity, leading to unpredictable immune responses in cell-based therapies.

Innovation Solution

A novel culture medium composition using Toll-like receptor (TLR) ligands and additional agents like neurotransmitters or lipids to induce uniform type 1 or type 2 phenotypes in multipotent stem cells, enhancing cytokine expression and migration efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to induce multipotent stem cells into specific inflammatory or anti-inflammatory phenotypes, then some level of phenotype induction is achieved, but the resulting cell populations are heterogeneous and exhibit unpredictable immune responses

Engineering Contradiction:
Improvephenotype uniformityVSAvoidpredictability of immune response
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically varying the concentration and combination of TLR ligands (such as LPS for TLR4, poly(I:C) for TLR3) and additional agents (neurotransmitters, lipids) in the culture medium to achieve uniform type 1 or type 2 phenotypes. By optimizing these parameters, the method produces homogenous cell populations with consistent pro-inflammatory or anti-inflammatory properties, thereby improving both manufacturing precision and reliability of immune response predictability

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If single TLR ligand stimulation is used, then the induction process is simple, but the resulting cell phenotype is insufficient or inconsistent

Engineering Contradiction:
Improvesimplicity of induction processVSAvoidphenotype consistency
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent merges the use of multiple TLR ligands with additional inducing agents (neurotransmitters like acetylcholine, serotonin; lipids like lipoxin A4, leukotriene B4) to create a synergistic induction system. This combination approach enhances phenotype consistency and cellular response uniformity while maintaining practical ease of manufacture through standardized culture medium formulations

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The culture medium is formulated as a composite system containing multiple TLR ligands, neurotransmitters, and lipids in specific concentrations. This composite approach ensures consistent and robust induction of desired phenotypes, achieving both simplicity in application and precision in outcome through the integrated formulation

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method produces homogenous stem cell populations with consistent pro-inflammatory or anti-inflammatory properties, improving the safety and efficacy of cell-based therapies for conditions like tumors and inflammatory disorders.

Implementation Method 1

Multipotent stem cells and mesenchymal stem cells can be induced from a naive or unstimulated state into a pro-inflammatory (type 1) or an anti-inflammatory (type 2) phenotype via the selective stimulation of Toll-like receivers

Methodology Applied
Scientific EffectToll-like receptor signaling:

Data Source

PatentUS12553033B2Medium, methods, cells and secreted factors for stem cell culture and therapy
Publication Date: 2026.02.17 SANBIO INC
  • US12553033B2 patent drawing
  • US12553033B2 patent drawing
  • US12553033B2 patent drawing

AI summary

Described herein are methods and culture medium, useful for inducing polarization in multipotent stem cells. Additionally, described herein are multipotent cells produced by the methods and culture medium of this disclosure that are useful therapeutic agents. Also described herein are extracellular vesicles and factors secreted by multipotent cells that are produced by the methods and culture medium of this disclosure that are useful as therapeutic agents.